| Swarajya Lakshmi Vemuri, MD | |
|
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
| (888) 988-2800 | |
| Not Available |
| Full Name | Swarajya Lakshmi Vemuri |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 441 N Lakeview Ave, Anaheim, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174671127 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A67318 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Orange County - Anahe | Anaheim, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced today that it has signed a statement of intent with the World Health Organization to supply free of charge a primary medicine for the treatment of lymphatic filariasis.
After close cooperation with researchers at the Norwegian Institute for Agricultural and Environmental Research (Bioforsk), Norwegian grain dealers are implementing a newly devised computational model and rapid screening tests to improve control of toxins in Norwegian cereals.
The International and American Associations for Dental Research have published two studies about dental caries in children. These articles, titled "Hypoplasia-Associated Severe Early Childhood Caries - A Proposed Definition" and "Deciduous Molar Hypomineralization and Molar Incisor Hypomineralization" discuss the definitions of dental caries susceptibility to the hypomineralization and hypoplasia.
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with Hammersmith Hospitals NHS Trust (London, UK) to develop Phased Array High-Intensity Focused Ultrasound (HIFU) for the treatment of cancer.
Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa.
› Verified 1 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced today that it has signed a statement of intent with the World Health Organization to supply free of charge a primary medicine for the treatment of lymphatic filariasis.
After close cooperation with researchers at the Norwegian Institute for Agricultural and Environmental Research (Bioforsk), Norwegian grain dealers are implementing a newly devised computational model and rapid screening tests to improve control of toxins in Norwegian cereals.
The International and American Associations for Dental Research have published two studies about dental caries in children. These articles, titled "Hypoplasia-Associated Severe Early Childhood Caries - A Proposed Definition" and "Deciduous Molar Hypomineralization and Molar Incisor Hypomineralization" discuss the definitions of dental caries susceptibility to the hypomineralization and hypoplasia.
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with Hammersmith Hospitals NHS Trust (London, UK) to develop Phased Array High-Intensity Focused Ultrasound (HIFU) for the treatment of cancer.
Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Swarajya Lakshmi Vemuri, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Swarajya Lakshmi Vemuri, MD 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced today that it has signed a statement of intent with the World Health Organization to supply free of charge a primary medicine for the treatment of lymphatic filariasis.
After close cooperation with researchers at the Norwegian Institute for Agricultural and Environmental Research (Bioforsk), Norwegian grain dealers are implementing a newly devised computational model and rapid screening tests to improve control of toxins in Norwegian cereals.
The International and American Associations for Dental Research have published two studies about dental caries in children. These articles, titled "Hypoplasia-Associated Severe Early Childhood Caries - A Proposed Definition" and "Deciduous Molar Hypomineralization and Molar Incisor Hypomineralization" discuss the definitions of dental caries susceptibility to the hypomineralization and hypoplasia.
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, today announce that they have entered into an agreement with Hammersmith Hospitals NHS Trust (London, UK) to develop Phased Array High-Intensity Focused Ultrasound (HIFU) for the treatment of cancer.
Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa.
› Verified 1 days ago
Richard Eugene Hughes, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1300 N. Kraemer Blvd., Anaheim, CA 92806 Phone: 714-630-6363 Fax: 714-630-1921 | |
Michael Salvaggio, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Kaiser Permanente-orange County, 411 N. Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4594 | |
Abraham Harn, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave Ste 404, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Aleem A Syed, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, Suite 702, Anaheim, CA 92801 Phone: 714-533-0300 Fax: 714-533-0700 | |
Dr. Jagminder Singh Bhalla, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1781 W Romneya Dr, Ste C, Anaheim, CA 92801 Phone: 714-956-3160 Fax: 714-956-1188 | |
Dr. Ashley E. Mires, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1211 W La Palma Ave, #207, Anaheim, CA 92801 Phone: 714-772-8282 Fax: 714-772-6493 | |
Hyon Chong Seo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |